Skip to content

Artivion AORT Stock-Based Comp

Stock-Based Comp at other companies

Medtronic logo
MedtronicMDT
Merit Medical Systems logo
Merit Medical SystemsMMSI
TFX
TeleflexTFX
Globus Medical logo
Globus MedicalGMED
LivaNova logo
LivaNovaLIVN
Haemonetics logo
HaemoneticsHAE

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's stock-based comp?
Artivion (AORT) reported stock-based comp of $8.41M in Q1 2026.
How has Artivion's stock-based comp changed year-over-year?
Artivion's stock-based comp increased by 4.6% year-over-year, from $8.05M to $8.41M.
What is the long-term trend for Artivion's stock-based comp?
Over 4 years (2021 to 2025), Artivion's stock-based comp has grown at a 22.8% compound annual growth rate (CAGR), from $10.71M to $24.39M.